Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Seriously when are they going to unblind P3 trial data.....I never seen any biotech company with this behavior.
If something smells fishy then its fish I guess.
99.9999% chance they failed primary end point (PFS), but there is a ray of hope in Secondary endpoint (OS). OS is the key endpoint in oncology. This management is crooked and dont tell the truth to investors and still waiting for unblinded data....could take several months to years. Some people on this board are day dreaming and lying to themselves. This investment as good odds as lottery ticket especially with this management. Good luck.
What are they waiting for ? NWBO met all predefined endpoints more than year ago....data mining on failed trial ? Never seen this before in any of pivotal trials that sponser didn't disclose data even after they met predifined endpoints....
Did you ever see a Pivotal P3 trial data not disclosed by any company after they reached number required events for primary endpoint ? They reached predefined OS and PFS events almost a year ago yet they didn’t disclose data...why ? People still talking about blinded data publication...pure BS and classic retail fantasy....this company and management are junk.
DcVax failed primary endpoint in P3 trial (99.99%)...they are trying get something out of OS data...time will tell if there will be anything good come of othat or not...this is the Bottomline of the story no matter how you spin it...
Man this will go down as longest P3 trial in the history of man kind.....
Are you talking about 2020 ASCO ?
Anyone believe that NWBO will ever release P3 data ?
Are we going to talk sbout this draft publication in 2019 and 2020 too....
Well said, I hope SEC investigate this...again this isn’t uncommon with small/micro cap biotech management looting of retail investors money. Some of the long term investors still can’t accept the truth and lying to themselves by putting brave face....Even if P3 trial wins long term investors already lost the bet....and management continues to suck the blood out of investors. Endless lies....
Science is one of ghe top tier journals with impact factor ~30. It took me less than 2 months after I submit manuscript. Most of other journals I published are around the same timeline. I guess if you dont (haven’t) submitted manuscript then it will take infinite time....that exactly the case for NWBO. Go and take a look at some of P3 trial publications they have time line on when they submit and accepted for publication.
Just read last 2 years PR again...you will get a clear picture of this management. Period
I published several papers in top tier journals including Science....once you submit manuscript it takes less than 2 months to publish (if there are additional revisions add 1 more month thats all). Generally the whole manuscript preparation and publication is 3-4 months process. Don’t believe a word that comes out of this management its nothing but lies ( you should have known this by now). I don’t think they even submit a manuscript.....its all pure BS.
Bottomline they didn’t submit a manuscript and never going to...
It depends on how many billions of outstanding shares they will have at that...LMFAO
Man...this publication and P3 data release fiasco will drag for another one year atleast. They screwed us all. LP will be talking same old BS again next year.
BTW what happened to ASM presentation and supposed publication?
99% sure that exactly going to happen. We all walk away from this conference with out any real update on P3 data. Mark my words.
How many of you holding breath for coming Tuesday presentation ? Another huge disappointment on the cards. If my guess is right there won’t be any new data. I don’t think we will see any P3 dat until this summer. We will be lucky if they present P3 data at this ASCO.
Wow it’s really big list of updates, but unfortunately we are yet to have meaningful update on P3 trial that stopped recruitment 30 months back...when do expect p3 data read out ? What are the real reason’s for hold up ? Really frustrated with this pathetic management.
No matter how you spin it, This raise is clear indication that no data for another 6 months.
Does any one know for certain that when we will have P3 trial OS data otherthan baseless speculations ?
Hopefully this is not another run up for capital raise...
Yeah right, lets blame BP for all the failures....This management is the world class, didnt put a foot wrong in past decade or so...btw It isnt the first time we hear that micro/nano cap biotech investors blaming the BP for company and management failures. MRK, BMY, Pfizer, Roche, AZN joined the hands to take down NWBO. LMFAO
Common sense and simple logic...If there was good reason for clinical hold, company would have come with all their guns blazing to announce the news....why do you think FDA put them on clinical hold. Probably NWBO is the only company I am aware of it didnt disclose reasons for clinical hold. No matter how we spin it..clinical hold wasnt a good news...it took them 16 months to lift clinical hold why ? Did FDA/DMC found some clinical benefits or possibility in terms of OS in this trial ? No one knows...
Most people thinking this $500k raise bcz data is coming in 2 weeks...another way to look at is, probably they couldn’t raise more than 500k and waiting for shareholders meeting to increase authorized share count from 450M to ?
NWBO could have requested FDA that they will not enroll any new patients and continue collect OS (secondary endpoints). Especially in Cancer trial it is very much possible that you could fail to stop the disease progression but can improve overall survival....
Seriously what is preventing them disclosing PFS and OS data after pre-specified events occurred ? I never seen a company that didnt disclose results after they met pre-set events....something is really fishy about whole thing. Either they didnt met both primary and secondary endpoints and digging for subset....You can not compare this trail OS data with other trial SOC bcz no two patients are same and can have completely different prognosis.
First let them disclose P3 data before we even discuss AA and other regulatory approvals...They already passed pre-set PFS and OS events....what are we waiting for ?
Anyone expecting P3 trial results this year ? Some folks here dont have a clue about regulatory approvals...and misleading most of the people by saying AA is on the cards...pure BS. Most likely scenario FDA put a clinical hold on trial bcz futility in primary endpoint (PFS). NWBO might have requested them that they will not enroll anymore patients and there could be some hope in the form of OS hence they FDA lifted clinical hold. It happened earlier..
LMFAO, We have seen many of those pump statements over the years....and here we are still waiting for P3 data.
Any update on what did you find out ?
I dont think sabby holds any more shares...
https://whalewisdom.com/stock/nwbo-2
I am long stock (At this I am prepared to lose all my investment), one has to crazy and out of their fracking mind to be shorting this stock....didn't we hear the same thing couple of years back that we don't need to worry about cach. I am fed with these baseless pumping of this stock several people here. Wake me when they release P3 data...
Interesting people are dreaming about future Share Price...but the reality is where is next financing coming from and at what cost ?
Any more rumors about when do they release data ? not sure what is the trigger here...they already have sufficient PFS and OS events....what are they waiting for...
Bottomline is no one has a clue when P3 data will be released (including Management). It could be tomorrow or 2 years from now (if they could survive that long). This is beyond frustration for longs (most of us, including me are bag holders at this point). Management never revealed the truth why clinical trial was put on hold and later lifted. Longs deserve some answers from management and clear/definitive timeline after all this fiasco past 2 years. People should stop worth less pumping about deals, AA, BTD and other approvals. First let them disclose data....Hopefully longs could salvage some thing out of this.
Yeah right blame it everything on shorts and AF but not management and thier actions. Not sure how long we have to wait for data ? Btw who is in the right mind to short OTC penny stock (most of them covered long time back)? We definitely need some to blame...so lets blame imaginary short sellers. What happened to BP conspiracies against NWBO ?
Even $VBLT expect to have top line results in 1Q2018 and we are still waiting here....no one knows when do they release data....
These days e-prints (online publication of accepted paper) are pretty quick with in a week after accepted for publication. But in official journal it could take 1-2 months. But the whole process after they submit article will take 2-3 months minimum. If it is high impact journal it will take even longer...due to revisions/corrections.
Once submitted it to journal it will take at least 4-6 weeks for external review and if there are no corrections they will accept right away. If they have any corrections it will take another 4 weeks. My understanding is they didnt even submit for publication...those who familiar to this process know that realistically we are expecting towards the end of this year or early next year (holidays season wont help getting those reviews out fast).
So according to your predictions 20% of SOC patients live beyond 3 years ? Is it due to crossover effect?